Related Experiment Video
Updated: Jun 25, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Androgen receptor gene polymorphism and the metabolic syndrome in 60-80 years old Norwegian men
Paal André Skjaerpe1, Yvonne L Giwercman, Aleksander Giwercman
1Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway. Paal.Skjerpe@fagmed.uit.no
Abstract:
The metabolic syndrome (MS) includes a clustering of metabolic derangements. Low testosterone levels have been shown to be associated with both components of MS and MS per se. As most androgen-related effects are mediated thorough the androgen receptor (AR), we wanted to investigate to which degree the AR CAG and GGN repeat polymorphisms might be related to MS. Sixty-eight men, 60-80 years old, with subnormal total testosterone levels (
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenomics: Identification of New Drug Targets
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
